Review of current ECG consumer electronics (pros and cons)

被引:12
作者
Hilbel, Thomas [1 ,2 ,3 ]
Frey, Norbert [1 ]
机构
[1] Univ Hosp, Dept Cardiol, Heidelberg, Germany
[2] Univ Appl Sci, Dept Biomed Engn, Gelsenkirchen, Germany
[3] Heidelberg Univ Hosp, Dept Cardiol, Neuenheimer Feld 410, D-69120 Heidelberg, Germany
关键词
ECG; Wearables; Stroke; Atrial fibrillation; Ambulatory electrocardiography monitoring; Biomedical sensors; Event monitors; Cardiac arrhythmias; Cardiology; Electrocardiography; Electrocardiogram; Telemedicine; ATRIAL-FIBRILLATION; RISK-FACTOR; STROKE; MAP;
D O I
10.1016/j.jelectrocard.2022.11.010
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Several wearable, medical-grade consumer ECG devices are now available and integrated into consumer electronics like multi sensor fitness watches and scales. Specific consumer ECGs can also come in the form of patches or thin sensor plates in credit card or other shapes. Watches with ECG capabilities are often multi vital sign sensor devices. The majority of these devices are usually connected to a mobile smartphone. However, there are pros and cons to their use.Methods: We review here an exemplary selection of modern consumer ECG devices based on device type, recording method and the number of standard ECG channels derived.Results: Single-channel consumer ECG devices such as Smart Watches can be useful for detecting and monitoring atrial fibrillation and flutter and other arrhythmias, as well as ectopic complexes. However, they are currently limited with respect to recording duration and information content (a single-channel or limb-lead ECG having less diagnostic information than a 12-lead ECG). While some non watch-based consumer ECG devices can now record all 6 limb leads to yield increased information, no consumer ECG devices can currently reliably detect STsegment deviations, potentially indicating myocardial infarction or ischemic episodes. Moreover, barriers to use still exist for at-risk elderly people. Finally, there currently is no universal data exchange format.Conclusion: Consumer ECG devices, whether in fitness or fashionable design, allow for reliable detection of atrial fibrillation. Timely detection of atrial fibrillation and subsequent treatment might protect against stroke, especially in high-risk groups, yet prospective evidence is still lacking. Six-channel consumer ECG and longer data collection capabilities extend potential functionality, including for the monitoring of ST-segments and QT intervals. However, no currently available devices are sufficiently suitable for the detection of myocardial infarction or ischemia, which is why portable 12-channel technologies are desirable. For the reliable detection of a myocardial infarction, the determination of specific myocardial infarction blood markers and evaluation of patient medical history still is indispensable in addition to the 12 lead ECG.
引用
收藏
页码:23 / 28
页数:6
相关论文
共 23 条
[11]  
Knauermann Global, GES KNAUERM PROPLUS
[12]   Refining Clinical Risk Stratification for Predicting Stroke and Thromboembolism in Atrial Fibrillation Using a Novel Risk Factor-Based Approach The Euro Heart Survey on Atrial Fibrillation [J].
Lip, Gregory Y. H. ;
Nieuwlaat, Robby ;
Pisters, Ron ;
Lane, Deirdre A. ;
Crijns, Harry J. G. M. .
CHEST, 2010, 137 (02) :263-272
[13]   Comparison of the 80-lead body surface map to physician and to 12-lead electrocardiogram in detection of acute myocardial infarction [J].
McClelland, AJJ ;
Owens, CG ;
Menown, IBA ;
Lown, M ;
Adgey, AAJ .
AMERICAN JOURNAL OF CARDIOLOGY, 2003, 92 (03) :252-257
[14]   Application of High-Sensitivity Troponin in Suspected Myocardial Infarction [J].
Neumann, J. T. ;
Twerenbold, R. ;
Ojeda, F. ;
Soerensen, N. A. ;
Chapman, A. R. ;
Shah, A. S. V. ;
Anand, A. ;
Boeddinghaus, J. ;
Nestelberger, T. ;
Badertscher, P. ;
Mokhtari, A. ;
Pickering, J. W. ;
Troughton, R. W. ;
Greenslade, J. ;
Parsonage, W. ;
Mueller-Hennessen, M. ;
Gori, T. ;
Jernberg, T. ;
Morris, N. ;
Liebetrau, C. ;
Hamm, C. ;
Katus, H. A. ;
Muenzel, T. ;
Landmesser, U. ;
Salomaa, V. ;
Iacoviello, L. ;
Ferrario, M. M. ;
Giampaoli, S. ;
Kee, F. ;
Thorand, B. ;
Peters, A. ;
Borchini, R. ;
Jorgensen, T. ;
Soederberg, S. ;
Sans, S. ;
Tunstall-Pedoe, H. ;
Kuulasmaa, K. ;
Renne, T. ;
Lackner, K. J. ;
Worster, A. ;
Body, R. ;
Ekelund, U. ;
Kavsak, P. A. ;
Keller, T. ;
Lindahl, B. ;
Wild, P. ;
Giannitsis, E. ;
Than, M. ;
Cullen, L. A. ;
Mills, N. L. .
NEW ENGLAND JOURNAL OF MEDICINE, 2019, 380 (26) :2529-2540
[15]  
Ornato JP, 2002, J AM COLL CARDIOL, V39, p332A
[16]   Prehospital 80-lad mapping: Does it add significantly to the diagnosis of acute coronary syndromes? [J].
Owens, CG ;
McClelland, AJJ ;
Walsh, SJ ;
Smith, BA ;
Tomlin, A ;
Riddell, JW ;
Stevenson, M ;
Adgey, AAJ .
JOURNAL OF ELECTROCARDIOLOGY, 2004, 37 :223-232
[17]  
Paluch AE, 2022, LANCET PUBLIC HEALTH, V7, pE219, DOI 10.1016/S2468-2667(21)00302-9
[18]   Steps per Day and All-Cause Mortality in Middle-aged Adults in the Coronary Artery Risk Development in Young Adults Study [J].
Paluch, Amanda E. ;
Gabriel, Kelley Pettee ;
Fulton, Janet E. ;
Lewis, Cora E. ;
Schreiner, Pamela J. ;
Sternfeld, Barbara ;
Sidney, Stephen ;
Siddique, Juned ;
Whitaker, Kara M. ;
Carnethon, Mercedes R. .
JAMA NETWORK OPEN, 2021, 4 (09)
[19]   Implantable loop recorder detection of atrial fibrillation to prevent stroke ( The LOOP Study): a randomised controlled trial [J].
Svendsen, Jesper H. ;
Diederichsen, Soren Z. ;
Hojberg, Soren ;
Krieger, Derk W. ;
Graff, Claus ;
Kronborg, Christian ;
Olesen, Morten S. ;
Nielsen, Jonas B. ;
Holst, Anders G. ;
Brandes, Axel ;
Haugan, Ketil J. ;
Kober, Lars .
LANCET, 2021, 398 (10310) :1507-1516
[20]   Clinical outcomes in systematic screening for atrial fibrillation (STROKESTOP): a multicentre, parallel group, unmasked, randomised controlled trial [J].
Svennberg, Emma ;
Friberg, Leif ;
Frykman, Viveka ;
Al-Khalili, Faris ;
Engdahl, Johan ;
Rosenqvist, Marten .
LANCET, 2021, 398 (10310) :1498-1506